X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18073) 18073
Publication (1718) 1718
Book Chapter (74) 74
Book Review (39) 39
Conference Proceeding (35) 35
Dissertation (29) 29
Magazine Article (15) 15
Newspaper Article (10) 10
Web Resource (3) 3
Data Set (2) 2
Trade Publication Article (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6563) 6563
animals (5414) 5414
valine (4878) 4878
male (4755) 4755
valine - analogs & derivatives (4532) 4532
index medicus (3916) 3916
female (3786) 3786
valine - metabolism (3036) 3036
valine - pharmacology (2546) 2546
rats (2445) 2445
biochemistry & molecular biology (2097) 2097
middle aged (1975) 1975
adult (1962) 1962
amino acids (1916) 1916
valine - genetics (1841) 1841
valsartan (1836) 1836
valine - therapeutic use (1833) 1833
kinetics (1604) 1604
leucine (1487) 1487
mutation (1435) 1435
valine - chemistry (1316) 1316
aged (1303) 1303
isoleucine (1270) 1270
amino acid sequence (1220) 1220
neurosciences (1189) 1189
research (1170) 1170
mice (1158) 1158
carbon isotopes (1061) 1061
molecular sequence data (1041) 1041
time factors (1032) 1032
in vitro techniques (1021) 1021
acyclovir - analogs & derivatives (996) 996
proteins (984) 984
tetrazoles - therapeutic use (958) 958
valine - administration & dosage (957) 957
analysis (896) 896
pharmacology & pharmacy (894) 894
leucine - metabolism (878) 878
alanine (869) 869
amino acids - metabolism (816) 816
glycine (770) 770
genotype (765) 765
phenylalanine (742) 742
models, molecular (731) 731
methionine (722) 722
acyclovir - therapeutic use (715) 715
hypertension - drug therapy (711) 711
binding sites (710) 710
methionine - genetics (707) 707
metabolism (703) 703
antiviral agents - therapeutic use (698) 698
tetrazoles - pharmacology (680) 680
research article (671) 671
protein conformation (639) 639
dose-response relationship, drug (637) 637
isoleucine - metabolism (633) 633
treatment outcome (609) 609
chemistry (602) 602
genetic aspects (600) 600
adolescent (592) 592
microbiology (585) 585
base sequence (574) 574
lysine (574) 574
expression (572) 572
antihypertensive agents - therapeutic use (569) 569
protein biosynthesis (565) 565
threonine (541) 541
valine - analysis (540) 540
blood pressure - drug effects (534) 534
article (533) 533
physiological aspects (531) 531
valine - blood (531) 531
protein binding (527) 527
tritium (527) 527
hydrogen-ion concentration (522) 522
peptides (521) 521
enzymes (499) 499
genes (498) 498
l-valine (493) 493
mutagenesis, site-directed (486) 486
biophysics (485) 485
hypertension (485) 485
drug therapy, combination (481) 481
amino acid substitution (464) 464
multidisciplinary sciences (464) 464
cells, cultured (458) 458
amino-acids (457) 457
escherichia coli - metabolism (450) 450
valine - adverse effects (450) 450
protein (448) 448
risk factors (446) 446
chemistry, multidisciplinary (443) 443
rats, sprague-dawley (440) 440
excitatory amino acid antagonists - pharmacology (439) 439
tetrazoles - administration & dosage (438) 438
temperature (435) 435
peripheral vascular disease (434) 434
escherichia-coli (433) 433
biotechnology & applied microbiology (431) 431
chromatography (422) 422
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17051) 17051
German (259) 259
Russian (250) 250
French (216) 216
Chinese (144) 144
Japanese (112) 112
Spanish (35) 35
Italian (33) 33
Hungarian (12) 12
Polish (12) 12
Ukrainian (10) 10
Korean (9) 9
Czech (8) 8
Dutch (7) 7
Romanian (5) 5
Swedish (5) 5
Turkish (5) 5
Portuguese (4) 4
Finnish (3) 3
Danish (2) 2
Norwegian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Greek (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biotechnology and Bioengineering, ISSN 0006-3592, 05/2011, Volume 108, Issue 5, pp. 1140 - 1147
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 16, pp. 1477 - 1490
In this large clinical trial, the angiotensin-receptor blocker valsartan reduced the risk of diabetes in patients with impaired glucose tolerance. However, the... 
FASTING GLUCOSE | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | METABOLIC SYNDROME | LIFE-STYLE INTERVENTIONS | PREVENTION | COMPONENTS | IMPAIRED GLUCOSE-TOLERANCE | MELLITUS | CONVERTING-ENZYME-INHIBITORS | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Phenylalanine - analogs & derivatives | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Body Weight - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cyclohexanes - therapeutic use | Glucose Intolerance - drug therapy | Exercise | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Phenylalanine - therapeutic use | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Blood Glucose - analysis | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Diabetes Mellitus, Type 2 - prevention & control | Proportional Hazards Models | Blood Glucose - drug effects | Glucose Intolerance - diet therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Tetrazoles - adverse effects | Valine - adverse effects | Glucose Intolerance - therapy | Evaluation | Care and treatment | Glucose intolerance | Diabetes | Cardiovascular diseases | Drug therapy | Cardiovascular disease | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Nature, ISSN 0028-0836, 10/2009, Volume 461, Issue 7266, pp. 968 - 970
alpha-Amino acids are the building blocks of proteins and are widely used as components of medicinally active molecules and chiral catalysts(1-5). Efficient... 
HEPATITIS-C-VIRUS | AGENTS | ADDITIONS | IMINES | MULTIDISCIPLINARY SCIENCES | CYANIDE | Valine - chemistry | Potassium Cyanide - chemistry | Valine - chemical synthesis | Valine - analogs & derivatives | Imines - chemistry | Ligands | Catalysis | Thiourea - chemistry | Hydrogenation | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9583, pp. 221 - 229
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 2007, Volume 20, Issue 1, pp. 11 - 20
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9579, pp. 2079 - 2087
Journal Article
Drugs, ISSN 0012-6667, 4/2018, Volume 78, Issue 5, pp. 525 - 541
Tardive dyskinesia (TD) encompasses the spectrum of iatrogenic hyperkinetic movement disorders following exposure to dopamine receptor-blocking agents (DRBAs).... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | MOVEMENT-DISORDERS | CONTROLLED-TRIAL | RISK-FACTORS | 2ND-GENERATION ANTIPSYCHOTICS | GINKGO-BILOBA | DOUBLE-BLIND | INDUCED EXTRAPYRAMIDAL SYNDROMES | PHARMACOLOGY & PHARMACY | TOXICOLOGY | RATING-SCALE | GENDER-DIFFERENCES | DRUG-INDUCED DYSKINESIA | Tetrabenazine - administration & dosage | Tetrabenazine - analogs & derivatives | Tardive Dyskinesia - drug therapy | Tourette Syndrome - drug therapy | United States | Antipsychotic Agents - adverse effects | Humans | Valine - analogs & derivatives | Vesicular Monoamine Transport Proteins - antagonists & inhibitors | Drug Approval | Valine - administration & dosage | Antipsychotic Agents - administration & dosage | Valine - chemistry | Antipsychotic Agents - chemistry | Antipsychotic Agents - therapeutic use | Tetrabenazine - chemistry | Valine - therapeutic use | Valine - adverse effects | Huntington Disease - drug therapy | Tetrabenazine - adverse effects | United States Food and Drug Administration | Tetrabenazine - therapeutic use | Drugs | Brain | Regulatory agencies | Neuroleptics | Deep brain stimulation | Medical services | Parkinsons disease | Disorders | Schizophrenia | Phenomenology | Psychotropic drugs | Metabolites | Gilles de la Tourette syndrome | Deuteration | Tardive dyskinesia | Movement disorders | Dyskinesia | Amantadine | Electroconvulsive therapy | Dopamine | Complications | Pharmacology | Tetrabenazine | FDA approval | Clonazepam | Vesicular amine transporter | Botulinum toxin | Side effects | Inhibitors | Monoamine transporter | Zolpidem | Psychiatry | Transporter
Journal Article
Drugs, ISSN 0012-6667, 07/2017, Volume 77, Issue 10, pp. 1123 - 1129
Valbenazine (Ingrezza (TM)) is an orally bioavailable, selective, vesicular monoamine transporter 2 (VMAT2) inhibitor being developed by Neurocrine... 
PHARMACOLOGY & PHARMACY | TOXICOLOGY | Tetrabenazine - analogs & derivatives | Tardive Dyskinesia - drug therapy | Tourette Syndrome - drug therapy | United States | Valine - pharmacokinetics | Humans |